The first Neogenomics trade was made in Q2 2016.
Since then Joel Greenblatt bought shares five more times and sold shares on eight occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Neogenomics anymore.
Avg closing price
Price range
Sold -12.8 Thousand shares
Q1 2024
Avg closing price
$15.44
Price range
$14.06
-
$16.79
Increased shares by 15.3% (+1.69 Thousand shares)
Q4 2023
Avg closing price
$16.36
Price range
$11.66
-
$20.73
Sold 74.3% shares (-32.1 Thousand shares)
Q3 2023
Avg closing price
$14.87
Price range
$12.15
-
$17.85
Increased shares by 292.6% (+32.2 Thousand shares)
Q2 2023